Preferential Langerhans cell differentiation from CD34 precursors upon introduction of ABCG2 (BCRP)

Immunology and Cell Biology

Volumn 90, Issue 2, 2012, Pages 206-215

  Van De Ven, Rieneke ^a   Lindenberg, Jelle J ^a   Reurs, Anneke W ^a   Scheper, Rik J ^a   Scheffer, George L ^a   De Gruijl, Tanja D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ABC transporters; MUTZ3 cell line; skin dendritic cell

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD209 ANTIGEN; INTERLEUKIN 4; LANGERIN; MESSENGER RNA; RETROVIRUS VECTOR; T6 ANTIGEN; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL DENDRITIC CELL; LANGERHANS CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD1; ANTIGENS, CD34; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; LEUKEMIA, MYELOID, ACUTE; NEOPLASM PROTEINS; SKIN; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857029857     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.25     Document Type: Article

References (50)

1. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ. Ins and outs of dendritic cells. Int Arch Allergy Immunol 2006; 140: 53-72.
2. van de Ven R, Scheffer GL, Scheper RJ, de Gruijl TD. The ABC of dendritic cell development and function. Trends Immunol 2009; 30: 421-429.
3. Laupeze B, Amiot L, Bertho N, Grosset JM, Lehne G, Fauchet R et al. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Hum Immunol 2001; 62: 1073-1080. (Pubitemid 32971384)
4. van de Ven R, de Jong MC, Reurs AW, Schoonderwoerd AJ, Jansen G, Hooijberg JH et al. Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J Immunol 2006; 176: 5191-5198.
5. Schroeijers AB, Reurs AW, Scheffer GL, Stam AG, de Jong MC, Rustemeyer T et al. Upregulation of drug resistance-related vaults during dendritic cell development. J Immunol 2002; 168: 1572-1578. (Pubitemid 34135751)
6. Randolph GJ, Beaulieu S, Pope M, Sugawara I, Hoffman L, Steinman RM et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci USA 1998; 95: 6924-6929. (Pubitemid 28278083)
7. Robbiani DF, Finch RA, Jager D,Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000; 103: 757-768.
8. van de Ven R, Scheffer GL, Reurs AW, Lindenberg JJ, Oerlemans R, Jansen G et al. A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration. Blood 2008; 112: 2353-2359.
9. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998; 95: 15665-15670. (Pubitemid 29018757)
10. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028-1034. (Pubitemid 32937383)
11. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002; 99: 507-512. (Pubitemid 34533085)
12. Jonker JW, Buitelaar M, Wagenaar E, Van Der Valk MA, Scheffer GL, Scheper RJ et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002; 99: 15649-15654. (Pubitemid 35403986)
13. Allen JD, Schinkel AH. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol Cancer Ther 2002; 1: 427-434.
14. Krishnamurthy P, Schuetz JD. The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival. Biometals 2005; 18: 349-358. (Pubitemid 41298019)
15. Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 2001; 1520: 234-241. (Pubitemid 32868794)
16. Ee PL, Kamalakaran S, Tonetti D, He X, Ross DD, Beck WT. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res 2004; 64: 1247-1251. (Pubitemid 38235590)
17. Szatmari I, Vamosi G, Brazda P, Balint BL, Benko S, Széles L et al. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem 2006; 281: 23812-23823. (Pubitemid 44274157)
18. Bhattacharya S, Das A, Mallya K, Ahmad I. Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling. J Cell Sci 2007; 120: 2652-2662. (Pubitemid 47323873)
19. Hu ZB, Ma W, Zaborski M, MacLeod R, Quentmeier H, Drexler HG. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia 1996; 10: 1025-1040. (Pubitemid 26235937)
20. Masterson AJ, Sombroek CC, de Gruijl TD, Graus YM, van der Vliet HJ, Lougheed SM et al. MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 2002; 100: 701-703. (Pubitemid 34761140)
21. Santegoets SJ, Masterson AJ, van der Sluis PC, Lougheed SM, Fluitsma DM, van den Eertwegh AJ et al. A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor. J Leukoc Biol 2006; 80: 1337-1344. (Pubitemid 44904972)
22. Santegoets SJ, Bontkes HJ, Stam AG, Bhoelan F, Ruizendaal JJ, van den Eertwegh AJ et al. Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model. J Immunol 2008; 180: 4540-4549.
23. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH et al. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 1991; 63: 923-929.
24. Bontkes HJ, de Gruijl TD, Schuurhuis GJ, Scheper RJ, Meijer CJ, Hooijberg E. Expansion of dendritic cell precursors from human CD34(+) progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome. J Leukoc Biol 2002; 72: 321-329.
25. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002; 16: 257-270. (Pubitemid 34211965)
26. Cejas PJ, Carlson LM, Kolonias D, Zhang J, Lindner I, Billadeau DD et al. Regulation of RelB expression during the initiation of dendritic cell differentiation. Mol Cell Biol 2005; 25: 7900-7916. (Pubitemid 41170148)
27. Clark GJ, Gunningham S, Troy A, Vuckovic S, Hart DN. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 1999; 98: 189-196. (Pubitemid 29487639)
28. Caux C, Massacrier C, Dubois B, Valladeau J, Dezutter-Dambuyant C, Durand I et al. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol 1999; 66: 781-791. (Pubitemid 29532040)
29. Triel C, Vestergaard ME, Bolund L, Jensen TG, Jensen UB. Side population cells in human and mouse epidermis lack stem cell characteristics. Exp Cell Res 2004; 295: 79-90. (Pubitemid 38407347)
30. de Paiva CS, Chen Z, Corrales RM, Pflugfelder SC, Li DQ. ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. Stem Cells 2005; 23: 63-73. (Pubitemid 40105292)
31. Chen W, Hara K, Tian Q, Zhao K, Yoshitomi T. Existence of small slow-cycling Langerhans cells in the limbal basal epithelium that express ABCG2. Exp Eye Res 2007; 84: 626-634. (Pubitemid 46400630)
32. Platzer B, Jorgl A, Taschner S, Hocher B, Strobl H. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 2004; 104: 3655-3663. (Pubitemid 39564442)
33. Gosset P, Charbonnier AS, Delerive P, Fontaine J, Staels B, Pestel J et al. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol 2001; 31: 2857-2865. (Pubitemid 32994536)
34. Nencioni A, Grunebach F, Zobywlaski A, Denzlinger C, Brugger W, Brossart P. Dendritic cell immunogenicity is regulated by peroxisome proliferator- activated receptor gamma. J Immunol 2002; 169: 1228-1235. (Pubitemid 34809163)
35. Angeli V, Hammad H, Staels B, Capron M, Lambrecht BN, Trottein F. Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response. J Immunol 2003; 170: 5295-5301. (Pubitemid 36554764)
36. Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005; 106: 3888-3894. (Pubitemid 41739028)
37. Momburg F, Roelse J, Hammerling GJ, Neefjes JJ. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 1994; 179: 1613-1623. (Pubitemid 24129578)
38. Robey RW, Polgar O, Deeken J, To KW, Bates SE. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 2007; 26: 39-57. (Pubitemid 46452182)
39. Miyazono K, Hellman U, Wernstedt C, Heldin CH. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem 1988; 263: 6407-6415.
40. Takada T, Suzuki H, Gotoh Y, Sugiyama Y. Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells. Drug Metab Dispos 2005; 33: 905-909. (Pubitemid 41002770)
41. Mogi M, Yang J, Lambert JF, Colvin GA, Shiojima I, Skurk C et al. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem 2003; 278: 39068-39075. (Pubitemid 37221810)
42. Carey GB, Semenova E, Qi X, Keegan AD. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway. Cell Res 2007; 17: 942-955. (Pubitemid 350126865)
43. Song K, Cornelius SC, Reiss M, Danielpour D. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 2003; 278: 38342-38351. (Pubitemid 37221726)
44. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002; 3: 1135-1141. (Pubitemid 35469697)
45. Yano S, Ito Y, Fujimoto M, Hamazaki TS, Tamaki K, Okochi H. Characterization and localization of side population cells in mouse skin. Stem Cells 2005; 23: 834-841. (Pubitemid 40791798)
46. van Loevezijn A, Allen JD, Schinkel AH, Koomen GJ. Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines. Bioorg Med Chem Lett 2001; 11: 29-32. (Pubitemid 32006117)
47. Takenaka K, Morgan JA, Scheffer GL, Adachi M, Stewart CF, Sun D et al. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. Cancer Res 2007; 67: 6965-6972. (Pubitemid 47105544)
48. van der Pol MA, Pater JM, Feller N et al. Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia. Leukemia 2001; 15: 1554-1563. (Pubitemid 32994674)
49. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001; 61: 3458-3464. (Pubitemid 32695041)
50. de Gruijl TD, Luykx-de Bakker SA, Tillman BW, van den Eertwegh AJ, Buter J, Lougheed SM et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol 2002; 169: 5322-5331. (Pubitemid 35217206)